RCM
HCA icon

Raleigh Capital Management’s HCA Healthcare HCA Stock Holding History

Raleigh Capital Management’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96K Sell
5
-9
-64% -$3.81K ﹤0.01% 434
2026
Q1 		$6.63K Buy
+14
New +$7.05K ﹤0.01% 411
2025
Q4 		– Hold
0
– – – 547
2025
Q3 		– Hold
0
– – – 520
2025
Q2 		– Sell
-47
Closed -$16.9K – 626
2025
Q1 		$16.2K Sell
47
-37
-44% -$11.9K 0.01% 335
2024
Q4 		$25.3K Sell
84
-417
-83% -$146K 0.01% 414
2024
Q3 		$204K Sell
501
-23
-4% -$8.42K 0.08% 198
2024
Q2 		$168K Buy
524
+201
+62% +$65.3K 0.07% 211
2024
Q1 		$108K Buy
323
+282
+688% +$86.2K 0.05% 235
2023
Q4 		$11.1K Buy
41
+27
+193% +$6.67K 0.01% 564
2023
Q3 		$3.47K Hold
14
– – ﹤0.01% 735
2023
Q2 		$4.27K Hold
14
– – ﹤0.01% 669
2023
Q1 		$3.7K Buy
+14
New +$3.56K ﹤0.01% 669
2022
Q4 		– Sell
-3
Closed -$1K – 824
2022
Q3 		$1K Hold
3
– – ﹤0.01% 739
2022
Q2 		$1K Hold
3
– – ﹤0.01% 578
2022
Q1 		$1K Buy
+3
New +$753 ﹤0.01% 570

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raleigh Capital Management's HCA Position: Q2 2026 in Review

Raleigh Capital Management reduced its HCA Healthcare (HCA) stake by 64% in Q2 2026, selling an estimated $3.81K and leaving 5 shares worth $1.96K. The position accounts for ﹤0.01% of the portfolio, ranked #434.

Raleigh Capital Management first reported a position in HCA in Q1 2022 and has held it in 14 quarters since. The position peaked at $204K in Q3 2024. 1,342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Raleigh Capital Management held 5 shares of HCA Healthcare worth $1.96K as of Q2 2026.
  • Raleigh Capital Management sold 9 HCA Healthcare shares in Q2 2026, an estimated $3.81K.
  • HCA Healthcare made up ﹤0.01% of Raleigh Capital Management's portfolio in Q2 2026, its #434 holding.
  • Raleigh Capital Management first reported a position in HCA Healthcare in Q1 2022 and has held it in 14 quarters since.
  • Raleigh Capital Management's HCA Healthcare position peaked at $204K in Q3 2024.
  • 1,342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.